The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Arthritic Therapeutic-Global Market Insights and Sales Trends 2024
Synopsis
The global Arthritic Therapeutic market size is expected to reach US$ 35210 million by 2029, growing at a CAGR of 3.7% from 2023 to 2029. The market is mainly driven by the significant applications of Arthritic Therapeutic in various end use industries. The expanding demands from the Rheumatoid Arthritis, Osteoarthritis, Psoriatic Arthritis and Ankylosing Spondylitis, are propelling Arthritic Therapeutic market. Biologics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Non-biologics segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Arthritic Therapeutic, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Arthritic Therapeutic market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Arthritic Therapeutic market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Arthritic Therapeutic sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Arthritic Therapeutic covered in this report include AbbVie, Merck., Novartis, AstraZeneca, Abbott, Amgen, Baxter, Bristol-Myers Squibb and F. Hoffmann-La Roche, etc.
The global Arthritic Therapeutic market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AbbVie
Merck.
Novartis
AstraZeneca
Abbott
Amgen
Baxter
Bristol-Myers Squibb
F. Hoffmann-La Roche
Eli Lilly
Johnson & Johnson
GlaxoSmithKline
Celgene
Pfizer
Global Arthritic Therapeutic market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Arthritic Therapeutic market, Segment by Type:
Biologics
Non-biologics
Global Arthritic Therapeutic market, by Application
Rheumatoid Arthritis
Osteoarthritis
Psoriatic Arthritis
Ankylosing Spondylitis
Fibromyalgia
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Arthritic Therapeutic companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Arthritic Therapeutic market size is expected to reach US$ 35210 million by 2029, growing at a CAGR of 3.7% from 2023 to 2029. The market is mainly driven by the significant applications of Arthritic Therapeutic in various end use industries. The expanding demands from the Rheumatoid Arthritis, Osteoarthritis, Psoriatic Arthritis and Ankylosing Spondylitis, are propelling Arthritic Therapeutic market. Biologics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Non-biologics segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Arthritic Therapeutic, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Arthritic Therapeutic market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Arthritic Therapeutic market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Arthritic Therapeutic sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Arthritic Therapeutic covered in this report include AbbVie, Merck., Novartis, AstraZeneca, Abbott, Amgen, Baxter, Bristol-Myers Squibb and F. Hoffmann-La Roche, etc.
The global Arthritic Therapeutic market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AbbVie
Merck.
Novartis
AstraZeneca
Abbott
Amgen
Baxter
Bristol-Myers Squibb
F. Hoffmann-La Roche
Eli Lilly
Johnson & Johnson
GlaxoSmithKline
Celgene
Pfizer
Global Arthritic Therapeutic market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Arthritic Therapeutic market, Segment by Type:
Biologics
Non-biologics
Global Arthritic Therapeutic market, by Application
Rheumatoid Arthritis
Osteoarthritis
Psoriatic Arthritis
Ankylosing Spondylitis
Fibromyalgia
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Arthritic Therapeutic companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Arthritic Therapeutic
1.1 Arthritic Therapeutic Market Overview
1.1.1 Arthritic Therapeutic Product Scope
1.1.2 Arthritic Therapeutic Market Status and Outlook
1.2 Global Arthritic Therapeutic Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Arthritic Therapeutic Market Size by Region (2018-2029)
1.4 Global Arthritic Therapeutic Historic Market Size by Region (2018-2023)
1.5 Global Arthritic Therapeutic Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Arthritic Therapeutic Market Size (2018-2029)
1.6.1 North America Arthritic Therapeutic Market Size (2018-2029)
1.6.2 Europe Arthritic Therapeutic Market Size (2018-2029)
1.6.3 Asia-Pacific Arthritic Therapeutic Market Size (2018-2029)
1.6.4 Latin America Arthritic Therapeutic Market Size (2018-2029)
1.6.5 Middle East & Africa Arthritic Therapeutic Market Size (2018-2029)
2 Arthritic Therapeutic Market by Type
2.1 Introduction
2.1.1 Biologics
2.1.2 Non-biologics
2.2 Global Arthritic Therapeutic Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Arthritic Therapeutic Historic Market Size by Type (2018-2023)
2.2.2 Global Arthritic Therapeutic Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Arthritic Therapeutic Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Arthritic Therapeutic Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Arthritic Therapeutic Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Arthritic Therapeutic Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Arthritic Therapeutic Revenue Breakdown by Type (2018-2029)
3 Arthritic Therapeutic Market Overview by Application
3.1 Introduction
3.1.1 Rheumatoid Arthritis
3.1.2 Osteoarthritis
3.1.3 Psoriatic Arthritis
3.1.4 Ankylosing Spondylitis
3.1.5 Fibromyalgia
3.1.6 Others
3.2 Global Arthritic Therapeutic Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Arthritic Therapeutic Historic Market Size by Application (2018-2023)
3.2.2 Global Arthritic Therapeutic Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Arthritic Therapeutic Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Arthritic Therapeutic Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Arthritic Therapeutic Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Arthritic Therapeutic Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Arthritic Therapeutic Revenue Breakdown by Application (2018-2029)
4 Arthritic Therapeutic Competition Analysis by Players
4.1 Global Arthritic Therapeutic Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Arthritic Therapeutic as of 2022)
4.3 Date of Key Players Enter into Arthritic Therapeutic Market
4.4 Global Top Players Arthritic Therapeutic Headquarters and Area Served
4.5 Key Players Arthritic Therapeutic Product Solution and Service
4.6 Competitive Status
4.6.1 Arthritic Therapeutic Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 AbbVie
5.1.1 AbbVie Profile
5.1.2 AbbVie Main Business
5.1.3 AbbVie Arthritic Therapeutic Products, Services and Solutions
5.1.4 AbbVie Arthritic Therapeutic Revenue (US$ Million) & (2018-2023)
5.1.5 AbbVie Recent Developments
5.2 Merck.
5.2.1 Merck. Profile
5.2.2 Merck. Main Business
5.2.3 Merck. Arthritic Therapeutic Products, Services and Solutions
5.2.4 Merck. Arthritic Therapeutic Revenue (US$ Million) & (2018-2023)
5.2.5 Merck. Recent Developments
5.3 Novartis
5.3.1 Novartis Profile
5.3.2 Novartis Main Business
5.3.3 Novartis Arthritic Therapeutic Products, Services and Solutions
5.3.4 Novartis Arthritic Therapeutic Revenue (US$ Million) & (2018-2023)
5.3.5 AstraZeneca Recent Developments
5.4 AstraZeneca
5.4.1 AstraZeneca Profile
5.4.2 AstraZeneca Main Business
5.4.3 AstraZeneca Arthritic Therapeutic Products, Services and Solutions
5.4.4 AstraZeneca Arthritic Therapeutic Revenue (US$ Million) & (2018-2023)
5.4.5 AstraZeneca Recent Developments
5.5 Abbott
5.5.1 Abbott Profile
5.5.2 Abbott Main Business
5.5.3 Abbott Arthritic Therapeutic Products, Services and Solutions
5.5.4 Abbott Arthritic Therapeutic Revenue (US$ Million) & (2018-2023)
5.5.5 Abbott Recent Developments
5.6 Amgen
5.6.1 Amgen Profile
5.6.2 Amgen Main Business
5.6.3 Amgen Arthritic Therapeutic Products, Services and Solutions
5.6.4 Amgen Arthritic Therapeutic Revenue (US$ Million) & (2018-2023)
5.6.5 Amgen Recent Developments
5.7 Baxter
5.7.1 Baxter Profile
5.7.2 Baxter Main Business
5.7.3 Baxter Arthritic Therapeutic Products, Services and Solutions
5.7.4 Baxter Arthritic Therapeutic Revenue (US$ Million) & (2018-2023)
5.7.5 Baxter Recent Developments
5.8 Bristol-Myers Squibb
5.8.1 Bristol-Myers Squibb Profile
5.8.2 Bristol-Myers Squibb Main Business
5.8.3 Bristol-Myers Squibb Arthritic Therapeutic Products, Services and Solutions
5.8.4 Bristol-Myers Squibb Arthritic Therapeutic Revenue (US$ Million) & (2018-2023)
5.8.5 Bristol-Myers Squibb Recent Developments
5.9 F. Hoffmann-La Roche
5.9.1 F. Hoffmann-La Roche Profile
5.9.2 F. Hoffmann-La Roche Main Business
5.9.3 F. Hoffmann-La Roche Arthritic Therapeutic Products, Services and Solutions
5.9.4 F. Hoffmann-La Roche Arthritic Therapeutic Revenue (US$ Million) & (2018-2023)
5.9.5 F. Hoffmann-La Roche Recent Developments
5.10 Eli Lilly
5.10.1 Eli Lilly Profile
5.10.2 Eli Lilly Main Business
5.10.3 Eli Lilly Arthritic Therapeutic Products, Services and Solutions
5.10.4 Eli Lilly Arthritic Therapeutic Revenue (US$ Million) & (2018-2023)
5.10.5 Eli Lilly Recent Developments
5.11 Johnson & Johnson
5.11.1 Johnson & Johnson Profile
5.11.2 Johnson & Johnson Main Business
5.11.3 Johnson & Johnson Arthritic Therapeutic Products, Services and Solutions
5.11.4 Johnson & Johnson Arthritic Therapeutic Revenue (US$ Million) & (2018-2023)
5.11.5 Johnson & Johnson Recent Developments
5.12 GlaxoSmithKline
5.12.1 GlaxoSmithKline Profile
5.12.2 GlaxoSmithKline Main Business
5.12.3 GlaxoSmithKline Arthritic Therapeutic Products, Services and Solutions
5.12.4 GlaxoSmithKline Arthritic Therapeutic Revenue (US$ Million) & (2018-2023)
5.12.5 GlaxoSmithKline Recent Developments
5.13 Celgene
5.13.1 Celgene Profile
5.13.2 Celgene Main Business
5.13.3 Celgene Arthritic Therapeutic Products, Services and Solutions
5.13.4 Celgene Arthritic Therapeutic Revenue (US$ Million) & (2018-2023)
5.13.5 Celgene Recent Developments
5.14 Pfizer
5.14.1 Pfizer Profile
5.14.2 Pfizer Main Business
5.14.3 Pfizer Arthritic Therapeutic Products, Services and Solutions
5.14.4 Pfizer Arthritic Therapeutic Revenue (US$ Million) & (2018-2023)
5.14.5 Pfizer Recent Developments
6 North America
6.1 North America Arthritic Therapeutic Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Arthritic Therapeutic Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Arthritic Therapeutic Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Arthritic Therapeutic Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Arthritic Therapeutic Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Arthritic Therapeutic Market Dynamics
11.1 Arthritic Therapeutic Industry Trends
11.2 Arthritic Therapeutic Market Drivers
11.3 Arthritic Therapeutic Market Challenges
11.4 Arthritic Therapeutic Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
